BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15599674)

  • 1. [Coronary microembolization: perfusion-contraction mismatch secondary to myocardial inflammation].
    Skyschally A; Schulz R; Haude M; Erbel R; Heusch G
    Herz; 2004 Dec; 29(8):777-81. PubMed ID: 15599674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary microembolization.
    Skyschally A; Leineweber K; Gres P; Haude M; Erbel R; Heusch G
    Basic Res Cardiol; 2006 Sep; 101(5):373-82. PubMed ID: 16915530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary microembolization.
    Heusch G; Schulz R; Baumgart D; Haude M; Erbel R
    Prog Cardiovasc Dis; 2001; 44(3):217-30. PubMed ID: 11727279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microembolization.
    Heusch G; Schulz R; Haude M; Erbel R
    J Mol Cell Cardiol; 2004 Jul; 37(1):23-31. PubMed ID: 15242732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary microembolization: from bedside to bench and back to bedside.
    Heusch G; Kleinbongard P; Böse D; Levkau B; Haude M; Schulz R; Erbel R
    Circulation; 2009 Nov; 120(18):1822-36. PubMed ID: 19884481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary microembolization: the role of TNF-alpha in contractile dysfunction.
    Dörge H; Schulz R; Belosjorow S; Post H; van de Sand A; Konietzka I; Frede S; Hartung T; Vinten-Johansen J; Youker KA; Entman ML; Erbel R; Heusch G
    J Mol Cell Cardiol; 2002 Jan; 34(1):51-62. PubMed ID: 11812164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization.
    Skyschally A; Haude M; Dörge H; Thielmann M; Duschin A; van de Sand A; Konietzka I; Büchert A; Aker S; Massoudy P; Schulz R; Erbel R; Heusch G
    Circulation; 2004 May; 109(19):2337-42. PubMed ID: 15117838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary microembolization.
    Skyschally A; Erbel R; Heusch G
    Circ J; 2003 Apr; 67(4):279-86. PubMed ID: 12655156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory biomarkers of coronary atheromatous plaque vulnerability.
    Avanzas P; Arroyo-Espliguero R; Garcia-Moll X; Kaski JC
    Panminerva Med; 2005 Jun; 47(2):81-91. PubMed ID: 16210993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction.
    Skyschally A; Gres P; Hoffmann S; Haude M; Erbel R; Schulz R; Heusch G
    Circ Res; 2007 Jan; 100(1):140-6. PubMed ID: 17170366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microembolization--its role in acute coronary syndromes and interventions.
    Erbel R; Heusch G
    Herz; 1999 Nov; 24(7):558-75. PubMed ID: 10609163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation.
    Dörge H; Neumann T; Behrends M; Skyschally A; Schulz R; Kasper C; Erbel R; Heusch G
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2587-92. PubMed ID: 11087208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary microembolization and microvascular dysfunction.
    Heusch G; Skyschally A; Kleinbongard P
    Int J Cardiol; 2018 May; 258():17-23. PubMed ID: 29429637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fresh look at coronary microembolization.
    Kleinbongard P; Heusch G
    Nat Rev Cardiol; 2022 Apr; 19(4):265-280. PubMed ID: 34785770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
    Lerman A; Holmes DR; Herrmann J; Gersh BJ
    Eur Heart J; 2007 Apr; 28(7):788-97. PubMed ID: 17347176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular occlusions and coronary microembolization.
    Stenberg TA; Steigen T; Myrmel T
    Scand Cardiovasc J; 2011 Oct; 45(5):258-60. PubMed ID: 21879801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary microcirculation. Pathophysiology, clinical relevance, and importance for regenerative therapy after myocardial infarction].
    Schächinger V; Zeiher AM
    Herz; 2005 Nov; 30(7):641-50. PubMed ID: 16333592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced coronary and inotropic reserves with coronary microembolization.
    Skyschally A; Schulz R; Erbel R; Heusch G
    Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H611-4. PubMed ID: 11788409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from human coronary aspirate.
    Kleinbongard P; Konorza T; Böse D; Baars T; Haude M; Erbel R; Heusch G
    J Mol Cell Cardiol; 2012 Apr; 52(4):890-6. PubMed ID: 21762698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.